While the United States Drug Enforcement Agency’s marijuana research license isn’t awarded lightly, an Ohio-based organization was recently awarded a Schedule I Researcher license by the DEA to study the effects of marijuana.
Tag Archives: NIDA
COLUMBUS, Ohio, Oct. 31, 2017 /Weed Wire/ — Battelle announced today that it was awarded a Schedule I Researcher license by the U.S. Drug Enforcement Administration (DEA), paving the way for the leading research and development organization to conduct marijuana research with human subjects.
PHOENIX, March 17, 2017 /Weed Wire/ — As of March 15, 2017, five participants have received marijuana (cannabis) provided by the National Institute on Drug Abuse (NIDA) in an ongoing Phase 2 clinical trial sponsored by the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) at the Scottsdale Research Institute (SRI) in Phoenix, Ariz. MAPS is committed to sponsoring rigorous clinical research to develop cannabis into a prescription medicine through the Food and Drug Administration (FDA).
WASHINGTON, Dec. 13, 2016 /Weed Wire/ — The results of an annual survey of U.S. middle and high school students released Tuesday invalidate claims that reforming marijuana laws and debating legalization will lead to increased marijuana use among teens.
NEW YORK, Oct. 20, 2016 /Weed Wire/ — New research is providing a more detailed view into the structure of the human cannabinoid (CB1) receptor.
WASHINGTON, May 6, 2016 /Weed Wire/ — The Bureau of International Narcotics and Law Enforcement at the State Department has gone on record stating that the United States could issue multiple licenses for the cultivation of cannabis for medical and scientific purposes without violating the United Nations Single Convention on Narcotic Drugs treaty.
Weekly CannaBit for the week of Nov. 23, 2015: Since 1990, the percentage of 18 to 30 year olds who perceive “great risk” in occasionally smoking marijuana has fallen by approximately half.
Some in the marijuana industry, based on their experiences on the job in the period between 2009 and 2013, believe that this industry vertical is actually anti-recessionary, even if it is not entirely shielded by “market correcting” events.
The Department of Health and Human Services announced that researchers who want to conduct non-federally funded research involving marijuana will no longer have to submit study proposals for Public Health Service review.
A highly anticipated study slated to test the efficacy of marijuana on veterans with post-traumatic stress disorder is still in limbo, despite a recent announcement that the National Institute of Drug Administration is ready to supply the researchers with the marijuana that they need.
Cannabis is illegal in Texas. But that doesn’t mean investors in the state aren’t taking a serious look at the financial potential of the cannabis industry.
Calling all pot farmers: Uncle Sam is looking to buy.
Many were puzzled earlier this spring when Gov. Andrew Cuomo and the New York State legislature reached a deal to legalize medical marijuana, but only in vaporizable form and only for a list of conditions that changed up until the last moment.
As was expected by the appealing parties, Dr. Susan Sisley’s appeal for reinstatement to the University of Arizona faculty was denied. The decision is final, and subject to no further review according to a letter dated July 28, 2014, from Dr. Andrew Comrie, the Senior Vice President for Academic Affairs and Provost for the University of Arizona.
The Federal Government’s Drug Enforcement Administration (DEA) budgeted 21 kilograms of marijuana for 2014, but it just bumped that up to 650 kilograms.